SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Jan 26, 2026-- United Therapeutics Corporation (Nasdaq: UTHR) today announced positive results from its phase 1 study of miroliver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results